These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 16242244

  • 1. Impulsivity, inhibition and negative priming in ecstasy users.
    Dafters RI.
    Addict Behav; 2006 Aug; 31(8):1436-41. PubMed ID: 16242244
    [Abstract] [Full Text] [Related]

  • 2. Chronic ecstasy (MDMA) use is associated with deficits in task-switching but not inhibition or memory updating executive functions.
    Dafters RI.
    Drug Alcohol Depend; 2006 Jun 28; 83(2):181-4. PubMed ID: 16316723
    [Abstract] [Full Text] [Related]

  • 3. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
    Butler GK, Montgomery AM.
    Drug Alcohol Depend; 2004 Oct 05; 76(1):55-62. PubMed ID: 15380289
    [Abstract] [Full Text] [Related]

  • 4. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan 05; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 5. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul 05; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 6. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC.
    J Psychopharmacol; 2006 Mar 05; 20(2):147-63. PubMed ID: 16510474
    [Abstract] [Full Text] [Related]

  • 7. Evidence for executive deficits among users of MDMA (Ecstasy).
    Fisk JE, Montgomery C, Murphy P, Wareing M.
    Br J Psychol; 2004 Nov 05; 95(Pt 4):457-66. PubMed ID: 15527532
    [Abstract] [Full Text] [Related]

  • 8. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL, Hamilton C, Kennedy DO, Scholey AB.
    J Psychopharmacol; 2006 May 05; 20(3):385-8. PubMed ID: 16574712
    [Abstract] [Full Text] [Related]

  • 9. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar 05; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 10. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug 05; 27(5):819-27. PubMed ID: 12921915
    [Abstract] [Full Text] [Related]

  • 11. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM, Parrott AC, Schifano F, Turner JJ.
    Hum Psychopharmacol; 2005 Jun 05; 20(4):249-61. PubMed ID: 15816011
    [Abstract] [Full Text] [Related]

  • 12. Long-term effects of MDMA (Ecstasy) on the human central nervous system revealed by visual evoked potentials.
    Casco C, Forcella M, Beretta G, Grieco A, Campana G.
    Addict Biol; 2005 Jun 05; 10(2):187-95. PubMed ID: 16191672
    [Abstract] [Full Text] [Related]

  • 13. Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds.
    Bedi G, Redman J.
    Psychol Med; 2008 Sep 05; 38(9):1319-30. PubMed ID: 18226286
    [Abstract] [Full Text] [Related]

  • 14. Evidence of increased activation underlying cognitive control in ecstasy and cannabis users.
    Roberts GM, Garavan H.
    Neuroimage; 2010 Aug 15; 52(2):429-35. PubMed ID: 20417713
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence for selective executive function deficits in ecstasy/polydrug users.
    Fisk JE, Montgomery C.
    J Psychopharmacol; 2009 Jan 15; 23(1):40-50. PubMed ID: 18515461
    [Abstract] [Full Text] [Related]

  • 19. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K, Turner JJ, Parrott AC.
    J Psychopharmacol; 2006 May 15; 20(3):417-24. PubMed ID: 16574716
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.